FGF2 and leukemia: It has been demonstrated that fibroblast growth factor 2 (FGF2)-enriched exosomes from bone marrow stromal cells are endocytosed by leukemia cells (AML) and protect leukemia cells from tyrosine kinase inhibitors (TKIs).